| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 04/16/2003 | EP1301493A2 Heterocycle carboxamides as antiviral agents |
| 04/16/2003 | EP1301488A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| 04/16/2003 | CN1411461A Thienopyridine derivatives and their preparing process and use |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/15/2003 | US6548524 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/15/2003 | US6548515 Use as anticancer agents |
| 04/15/2003 | US6548493 Substituted heterocycle fused gamma-carbolines |
| 04/15/2003 | CA2070573C Derivatives of amide analogs of certain methano bridged quinolizines |
| 04/11/2003 | CA2506646A1 Serotonin transport inhibitors |
| 04/10/2003 | WO2003028733A1 Tetracyclic indole derivatives as 5-ht receptor ligands |
| 04/10/2003 | WO2002102793A3 Quinazolinediones as antibacterial agents |
| 04/10/2003 | WO2002071827A3 Retinoid x receptor modulators |
| 04/10/2003 | US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 04/10/2003 | US20030069275 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 04/10/2003 | US20030069267 Modulators of protein tyrosine phosphatases (PTPases) |
| 04/10/2003 | CA2453343A1 Tetracyclic indole derivatives as 5-ht receptor ligands |
| 04/09/2003 | EP1299394A1 Method for preparing (+)-biotine |
| 04/09/2003 | EP1299393A2 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 04/09/2003 | EP1299378A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 04/09/2003 | EP1299094A2 Selective androgen receptor modulators and methods for their identification, design and use |
| 04/09/2003 | EP0892793B1 Substituted tetracyclic tetrahydrofuran derivatives |
| 04/09/2003 | CN1105116C Thienopyrimidine with PDE V-inhibiting effect |
| 04/09/2003 | CN1105113C Fungicidal pyrimidinones |
| 04/08/2003 | USRE38073 Biosynthesis; using dehydration agent |
| 04/08/2003 | US6545033 GABA receptor inhibitors |
| 04/08/2003 | US6545014 Glaucoma; adjusting concentration of nitric oxide; hypotensive, antispasmodic, antiischemic, cardiotonic agents; bronchodilators; urogentital disorders; agonists, antagonists for endothelin receptors |
| 04/08/2003 | US6544979 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents |
| 04/08/2003 | CA2112165C Bicyclic amine derivatives |
| 04/08/2003 | CA2097824C Functionalized vinyl azoles and their use |
| 04/03/2003 | WO2002092563A3 Protease inhibitors |
| 04/03/2003 | US20030065182 Therapy for asthma, sexual disorders, hypotensive agents, analgesics |
| 04/03/2003 | US20030065018 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/03/2003 | US20030065007 Analgesics; psychological disorders; antidepressants |
| 04/03/2003 | US20030064997 Novel compounds |
| 04/03/2003 | US20030064985 Prevent virus reproduction |
| 04/03/2003 | US20030064982 Pyrazole compounds useful as protein kinase inhibitors |
| 04/03/2003 | US20030064981 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 04/03/2003 | US20030064979 Antiproliferative agent; antidiabetic agents |
| 04/03/2003 | US20030064954 Gene therapy; vaccines; calcium channel blockers; cardiovascular disorders |
| 04/03/2003 | DE20023184U1 New stable polymorphic forms of olanzapine, useful for treating psychotic conditions, mild anxiety and gastrointestinal conditions |
| 04/02/2003 | EP1298133A1 Procedure for the alkylation of 3,4-dihydroxythiophene-2,5-dicarboxylic esters |
| 04/02/2003 | EP1298132A1 Hydropyridine derivative acid addition salts |
| 04/02/2003 | EP1296990A2 Dihydropyridine compounds for the inhibition of calcium-influx |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP0770081B1 Heterocycle-condensed morphinoid derivatives |
| 04/02/2003 | CN1407988A Method for producing thienopyrimidines |
| 04/02/2003 | CN1407970A Urea compounds having muscarinic receptor antagonist activity |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541635 Silylprotected L-proline derivative or salt is deprotected in presence of a nonaqueous medium containing an organic solvent at a temperature of 5 degree C. to 40 degree C. |
| 04/01/2003 | US6541630 Fungicides |
| 04/01/2003 | US6541481 Substituted bicyclic derivatives useful as anticancer agents |
| 04/01/2003 | US6541477 Inhibitors of p38-a kinase |
| 04/01/2003 | US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 04/01/2003 | US6541470 Have a potent antiviral activity against picornaviruses and rotaviruses. |
| 03/28/2003 | WO2002026745A1 Thienopyrimidine compounds and their salts and process for preparation of both |
| 03/28/2003 | CA2423981A1 Thienopyrimidine compounds and salts thereof and process for the preparation of the same |
| 03/27/2003 | WO2003024973A1 Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 03/27/2003 | WO2003024971A1 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 03/27/2003 | WO2003024970A1 Compounds which inhibit the release of inflammatory cytokines |
| 03/27/2003 | WO2003024962A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 03/27/2003 | WO2003024936A1 Substituted pyrazolo compounds for the treatment of inflammation |
| 03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
| 03/27/2003 | US20030060462 Therapeutic compounds |
| 03/27/2003 | US20030059785 Detection of markers in nascent proteins |
| 03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
| 03/27/2003 | CA2461073A1 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 03/27/2003 | CA2461072A1 Compounds which inhibit the release of inflammatory cytokines |
| 03/27/2003 | CA2461071A1 Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 03/26/2003 | EP1294729A1 2-aminoalkyl-thieno[2,3-d]pyrimidines |
| 03/26/2003 | EP1294728A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD |
| 03/26/2003 | EP1294725A2 Multicyclic compounds and the use thereof as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 03/26/2003 | EP1294707A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 03/26/2003 | EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents |
| 03/26/2003 | CN1406239A Process for the production of thienopyrimidine derivatives |
| 03/25/2003 | WO2003000254A1 Fused cyclic compounds and medicinal use thereof |
| 03/25/2003 | US6538009 Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/25/2003 | US6538004 Potassium channel modulators relax smooth muscle cells and inhibit bladder contractions; treating nervous, eating, cardiovascular, gastrointestinal, and sexual disorders |
| 03/25/2003 | US6538002 In particular, these compounds are useful as modulators of the chemokine receptors CCR-5 and/or CCR-3. as antiinflammatory agents |
| 03/25/2003 | US6538000 9-(3-chloro-4-hydroxyphenyl)-5,6,7,9-tetrahydropyrazolo(5,1-b) quinazoline-8(4H)-one;for cardiovascular disorders |
| 03/25/2003 | CA2423800A1 Fused cyclic compounds and medicinal use thereof |
| 03/20/2003 | WO2003022856A1 Substituted 7-aza[2.2.1] bicycloheptanes for the treatment of diseases |
| 03/20/2003 | WO2003022852A2 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors |
| 03/20/2003 | WO2003022848A2 Process for the preparation of diketopyrrolopyrroles |
| 03/20/2003 | WO2003022847A2 Process for the direct preparation of pyrrolo[3,4-c]pyrroles |
| 03/20/2003 | WO2003022214A2 Piperazine and homopiperazine compounds |
| 03/20/2003 | WO2003022055A1 Pesticidal compositions |
| 03/20/2003 | US20030055286 Il-8 receptor antagonists |
| 03/20/2003 | US20030055269 Reacting a p-phenylacetic acid derivative in an acid halogenating reaction, reacting further with a malonic ester, magnesium alkoxide, sulfur and a nitriloacetic ester in the presence of a primary amine |
| 03/20/2003 | US20030055130 New thiophenes and polymers derived therefrom |
| 03/20/2003 | US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 03/20/2003 | US20030055068 Pyrazole compounds useful as protein kinase inhibitors |
| 03/20/2003 | US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient |
| 03/20/2003 | US20030055035 Useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions |
| 03/20/2003 | CA2460075A1 Substituted 7-aza[2.2.1] bicycloheptanes for the treatment of diseases |
| 03/20/2003 | CA2457710A1 Process for the direct preparation of pyrrolo¬3,4-c|pyrroles |
| 03/19/2003 | EP1293503A1 Triazole derivatives |
| 03/19/2003 | EP1292573A2 Substituted thioacetamides |
| 03/19/2003 | EP0799228B1 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as anti-parasitic agents |
| 03/19/2003 | CN1404470A 2-OXo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 03/19/2003 | CN1404469A 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |